Hepatitis D: Scenario in the Asia-Pacific region

World Journal of Gastroenterology

Volumn 16, Issue 5, 2010, Pages 554-562

  Abbas, Zaigham ^a   Jafri, Wasim ^b   Raza, Sajjad ^c  

^a SINDH INSTITUTE OF UROLOGY AND TRANSPLANTATION   (Pakistan)

^b AGA KHAN UNIVERSITY HOSPITAL   (Pakistan)

^c DOW UNIVERSITY OF HEALTH SCIENCES   (Pakistan)

Author keywords

Asia Pacific region; Epidemiology; Hepatitis D; Prevalence

Indexed keywords

HEPATITIS B SURFACE ANTIGEN; HEPATITIS DELTA ANTIGEN;

CHRONIC HEPATITIS; DELTA AGENT HEPATITIS; HEMODIALYSIS PATIENT; HEPATITIS B; HEPATITIS B VIRUS; HEPATITIS C; HEPATITIS C VIRUS; HEPATITIS DELTA VIRUS; HIGH RISK POPULATION; HUMAN; INCIDENCE; INFECTION PREVENTION; INTRAVENOUS DRUG ABUSE; IRAN; LESBIAN; MALE HOMOSEXUAL; PACIFIC ISLANDS; PAKISTAN; PROSTITUTION; REVIEW; SERODIAGNOSIS; SEROPREVALENCE; SOUTH ASIA; VACCINATION; VIRUS CARRIER; VIRUS TRANSMISSION;

EID: 76549113278     PISSN: 10079327     EISSN: None     Source Type: Journal    
DOI: 10.3748/wjg.v16.i5.554     Document Type: Review

References (102)

1. World Health Organization. Hepatitis Delta [WHO/CDS/CSR/NCS/2001. 1]. Available from: URL: http://www. searo.who.int/EN/Section10/Section1027- 9489.htm
2. Fonseca JC. [Hepatitis D] Rev Soc Bras Med Trop 2002; 35: 181-190
3. Rizzetto M. Hepatitis D: the comeback? Liver Int 2009; 29 Suppl 1: 140-142
4. Koytak ES, Yurdaydin C, Glenn JS. Hepatitis d. Curr Treat Options Gastroenterol 2007; 10: 456-463
5. Moatter T, Abbas Z, Shabir S, Jafri W. Clinical presentation and genotype of hepatitis delta in Karachi. World J Gastroenterol 2007; 13: 2604-2607
6. Shakil AO, Hadziyannis S, Hoofnagle JH, Di Bisceglie AM, Gerin JL, Casey JL. Geographic distribution and genetic variability of hepatitis delta virus genotype I. Virology 1997; 234: 160-167
7. Farci P. Delta hepatitis: an update. J Hepatol 2003; 39 Suppl 1: S212-S219
8. Casey JL, Brown TL, Colan EJ, Wignall FS, Gerin JL. A genotype of hepatitis D virus that occurs in northern South America. Proc Natl Acad Sci USA 1993; 90: 9016-9020
9. Hsieh TH, Liu CJ, Chen DS, Chen PJ. Natural course and treatment of hepatitis D virus infection. J Formos Med Assoc 2006; 105: 869-881
10. Mumtaz K, Hamid SS, Adil S, Afaq A, Islam M, Abid S, Shah HA, Jafri W. Epidemiology and clinical pattern of hepatitis delta virus infection in Pakistan. J Gastroenterol Hepatol 2005; 20: 1503-1507
11. Smedile A, Lavarini C, Farci P, Aricò S, Marinucci G, Dentico P, Giuliani G, Cargnel A, Del Vecchio Blanco C, Rizzetto M. Epidemiologic patterns of infection with the hepatitis B virus-associated delta agent in Italy. Am J Epidemiol 1983; 117: 223-229
12. Sagnelli E, Stroffolini T, Ascione A, Chiaramonte M, Craxì A, Giusti G, Piccinino F. Decrease in HDV endemicity in Italy. J Hepatol 1997; 26: 20-24
13. Navascués CA, Rodríguez M, Sotorrío NG, Sala P, Linares A, Suárez A, Rodrigo L. Epidemiology of hepatitis D virus infection: changes in the last 14 years. Am J Gastroenterol 1995; 90: 1981-1984
14. Seetlani NK, Abbas Z, Raza S, Yakoob J, Jafris W. Prevalence of hepatitis D in HBsAg positive patients visiting liver clinics. J Pak Med Assoc 2009; 59: 434-437
15. Chakraborty P, Kailash U, Jain A, Goyal R, Gupta RK, Das BC, Kar P. Seroprevalence of hepatitis D virus in patients with hepatitis B virus-related liver diseases. Indian J Med Res 2005; 122: 254-257
16. Irshad M, Acharya SK. Hepatitis D virus (HDV) infection in severe forms of liver diseases in north India. Eur J Gastroenterol Hepatol 1996; 8: 995-998
17. Singh V, Goenka MK, Bhasin DK, Kochhar R, Singh K. A study of hepatitis delta virus infection in patients with acute and chronic liver disease from northern India. J Viral Hepat 1995; 2: 151-154
18. Jaiswal SP, Chitnis DS, Artwani KK, Naik G, Jain AK. Prevalence of anti-delta antibodies in central India. Trop Gastroenterol 1999; 20: 29-32
19. Bhattacharyya S, Dalal BS, Lahiri A. Hepatitis D infectivity profile among hepatitis B infected hospitalised patients in Calcutta. Indian J Public Health 1998; 42: 108-112
20. Banker DD, Desai P, Brawner TA, Decker RH. Hepatitis delta virus infection in Bombay. Trans R Soc Trop Med Hyg 1992; 86: 424-425
21. Amarapurkar DN, Vishwanath N, Kumar A, Shankaran S, Murti P, Kalro RH, Desai HG. Prevalence of delta virus infection in high risk population and hepatitis B virus related liver diseases. Indian J Gastroenterol 1992; 11: 11-12
22. Ghuman HK, Kaur S. Delta-hepatitis. Indian J Pediatr 1995; 62: 691-693
23. Ghuman HK, Prabhakar H. Prevalence of hepatitis A, B, C & D in Ludhiana. Indian J Med Sci 1995; 49: 227-230
24. Thomas PP, Samuel BU, Jacob CK, John TJ, Shastry JC. Low prevalence of hepatitis D (delta) virus infection in a nephrology unit in south India. Trans R Soc Trop Med Hyg 1991; 85: 652-653
25. Murhekar MV, Murhekar KM, Arankalle VA, Sehgal SC. Hepatitis delta virus infection among the tribes of the Andaman and Nicobar Islands, India. Trans R Soc Trop Med Hyg 2005; 99: 483-484
26. Alavian SM. We have more data regarding epidemiology of hepatitis D in Iran but there are defects to be filled yet! Hepatitis Mon 2008; 8: 245-247
27. Shahinsaz L, Sabahi F, Karimi M, Behzadian F, Alavian SM, Zand V. Detection and genotyping of hepatitis D virus from HBsAg positive patients in Iran using RT-PCR. Iran J Biotechnol 2006; 4: 174-179
28. Taghavi SA, Sedighi S, Mehrabani D, Khademolhosseini F. Hepatitis D in Chronic Active Hepatitis B: Prevalence, Liver Enzyme Levels and Histopathology- an Epidemiological Study in Shiraz, Southern Iran, 2003-2004. Hepatitis Mon 2008; 8: 248-251
29. Rezvan H, Forouzandeh B, Taroyan S, Fadaiee S, Azordegan F. A study on delta virus infection and its clinical impact in Iran. Infection 1990; 18: 26-28
30. Karimi A, Amini S, Amirkhani A. Investigation and Comparison of hepatitis D prevalence in dialysis patients and the donors of HBsAg carrier. Teb va Tazkie 2000; 36: 30-35
31. Alavian SM, Assari Sh, Manzoori-Joybari H, Moghani Lankarani M, Doroudi T, Haji-Beigi B, Hajarizade B. Frequency and risk factors of hepatitis D virus in hepatitis B patients. Govaresh 2005; 10: 21-26
32. Gholamreza R, Shahryar S, Abbasali K, Hamidreza J, Abdolvahab M, Khodaberdi K, Danyal R, Nafiseh A. Seroprevalence of hepatitis B virus and its co-infection with hepatitis D virus and hepatitis C virus in Iranian adult population. Indian J Med Sci 2007; 61: 263-268
33. Roshandel G, Semnani S, Abdolahi N, Besharat S, Keshtkar AA, Joshaqani H, Moradi A, Kalavi K, Jabbari A, Kabir MJ, Hosseini SA, Sedaqat SM, Danesh A, Roshandel D, Hedayat-Mofidi SM. Prevalence of hepatitis D virus infection in hepatitis B surface antigen-positive subjects in Golestan province, northeast Iran. J Microbiol Immunol Infect 2008; 41: 227-230
34. Hassanjani Roshan MR, Beigi AA, Soleimani MJ. [Prevalence of anti-HDV in chronic carrier of HBV in Babol] Babol Med J 2002; 6: 50-54
35. Zahedi MJ. [Serologic Prevalence of Hepatitis D in HBsAg Positive Patients in Kerman, South of Iran, 2002-2003]. Kerman University of Medical Sciences and Health Services. 2003. Document No. 81/55
36. Torabi SE, Ebrahimpor S, Maljaie SH, Naghili B. Seroepidemiological study of HDV in HBsAg-positive individuals in Tabriz. Urmia Med J 2002; 4; 290-297
37. Vaziri S, Mansouri F, Sayad B, Afsharian M, Janbakhsh A, Karami M. Hepatitis D virus infection among HIV-HBV coinfected patients in Kermanshah, West of Iran. Hepatitis Mon 2008; 8: 252-257
38. Jacobson IM, Dienstag JL, Werner BG, Brettler DB, Levine PH, Mushahwar IK. Epidemiology and clinical impact of hepatitis D virus (delta) infection. Hepatology 1985; 5: 188-191
39. Wang DQ, Cheng HH, Minuk GY, Liu LH, Anand CM, Stowe TC, Wang HX, Ying DC, Tu YR, Buchan KA. Delta hepatitis virus infection in China. Int J Epidemiol 1987; 16: 79-83
40. Mai K. [Study on hepatitis delta virus infection in China] Zhonghua Liuxingbingxue Zazhi 1989; 10: 21-23
41. Hao LJ, Li L, Zhang YY, Song PH. A study on hepatitis D virus infection in liver tissues of patients with hepatitis B in China. J Tongji Med Univ 1990; 10: 65-68
42. Chen GH, Zhang MD, Huang W. Hepatitis delta virus superinfection in Guangzhou area. Chin Med J (Engl) 1990; 103: 451-454
43. Zhao X. [The seroepidemiological observation on hepatitis delta virus infection] Zhonghua Liuxingbingxue Zazhi 1990; 11: 202-204
44. Zhang JY, Jin ZH, Wang CJ. [A seroepidemiological study on hepatitis D virus (HDV) infection in Henan Province, China] Zhonghua Liuxingbingxue Zazhi 1995; 16: 365-368
45. Chen X, Xuan M, Yin Y. [Study of HDV infection in Shandong province] Zhonghua Liuxingbingxue Zazhi 1998; 19: 138-140
46. Li J, Wang J, Tian K, Wang Y, Zhang L, Huang H. Epidemiology of hepatitis B, C, D and G viruses and cytokine levels among intravenous drug users. J Huazhong Univ Sci Technolog Med Sci 2006; 26: 221-224
47. Lok AS, Wong A, Sporton S, Lai CL, Liu V, Chung HT. Hepatitis D virus superinfection remains a rare occurrence in non-drug abusers in Hong Kong. J Hepatol 1992; 14: 332-334
48. Chen DS. Viral hepatitis: from A to E, and beyond? J Formos Med Assoc 2003; 102: 671-679
49. Lu SN, Chen TM, Lee CM, Wang JH, Tung HD, Wu JC. Molecular epidemiological and clinical aspects of hepatitis D virus in a unique triple hepatitis viruses (B, C, D) endemic community in Taiwan. J Med Virol 2003; 70: 74-80
50. Huo TI, Wu JC, Lin RY, Sheng WY, Chang FY, Lee SD. Decreasing hepatitis D virus infection in Taiwan: an analysis of contributory factors. J Gastroenterol Hepatol 1997; 12: 747-751
51. Tsai JF, Margolis HS, Fields HA, Chang WY, Tsai JH. Hepatitis delta virus superinfection among patients with chronic hepatitis B in southern Taiwan. Scand J Infect Dis 1990; 22: 403-405
52. Wu JC, Wang YJ, Hwang SJ, Chen TZ, Wang YS, Lin HC, Lee SD, Sheng WY. Hepatitis D virus infection among prostitutes in Taiwan. J Gastroenterol Hepatol 1993; 8: 334-337
53. Chen CJ, Tseng SF, Lu CF, Lin HC, You SL, Chen CS, Hwang SJ, Hsieh SF, Hsu ST. Current seroepidemiology of hepatitis D virus infection among hepatitis B surface antigen carriers of general and high-risk populations in Taiwan. J Med Virol 1992; 38: 97-101
54. Kao JH, Chen PJ, Lai MY, Chen DS. Hepatitis D virus genotypes in intravenous drug users in taiwan: decreasing prevalence and lack of correlation with hepatitis B virus genotypes. J Clin Microbiol 2002; 40: 3047-3049
55. Hsu HM, Wang YF, Lo SH, Sun HC, Yip KK, Chen JS, Chuang CH, Chen DS. Hepatitis D virus infection among intravenous drug abusers in Taiwan: analysis of risk factors and liver function tests. J Med Virol 1990; 31: 76-81
56. Chung DC, Ko YC, Chen CJ, Chen ER, Wu CC, Wu PS. Seroepidemiology of hepatitis B virus, hepatitis D virus, and human immunodeficiency virus infections among parenteral drug abusers in southern Taiwan. J Med Virol 1989; 28: 215-218
57. Chen PJ, Chen DS, Chen CR, Chen YY, Chen HM, Lai MY, Sung JL. Delta infection in asymptomatic carriers of hepatitis B surface antigen: low prevalence of delta activity and effective suppression of hepatitis B virus replication. Hepatology 1988; 8: 1121-1124
58. Lee SD, Wang JY, Wu JC, Chiang YT, Tsai YT, Lo KJ. Hepatitis B and D virus infection among drug abusers in Taiwan. J Med Virol 1986; 20: 247-252
59. Hsu HY, Chang MH, Chen DS, Lee CY. Hepatitis D virus infection in children with acute or chronic hepatitis B virus infection in Taiwan. J Pediatr 1988; 112: 888-892
60. Sakugawa H, Nakasone H, Nakayoshi T, Kawakami Y, Miyazato S, Kinjo F, Saito A, Ma SP, Hotta H, Kinoshita M. Hepatitis delta virus genotype IIb predominates in an endemic area, Okinawa, Japan. J Med Virol 1999; 58: 366-372
61. Tamura I, Ichimura H, Koda T, Katayama S, Kurimura O, Kurimura T. Hepatitis delta virus infection in different time periods in Japan. J Gastroenterol Hepatol 1990; 5: 407-410
62. Iwanami E, Yano M, Koga M, Shirahama S, Tsuda T. Local spread of HDV infection transiently occurring in Japan. J Gastroenterol Hepatol 1993; 8: 565-568
63. Sakugawa H, Nakasone H, Shokita H, Nakayoshi T, Kinjo F, Saito A, Yamashiro A, Miyagi Y. Seroepidemiological study of hepatitis delta virus infection in Okinawa, Japan. J Med Virol 1995; 45: 312-315
64. Nakasone H, Sakugawa H, Shokita H, Nakayoshi T, Kawakami Y, Kinjo F, Saito A, Shinjo M, Adaniya H, Mizushima T, Taira M. Prevalence and clinical features of hepatitis delta virus infection in the Miyako Islands, Okinawa, Japan. J Gastroenterol 1998; 33: 850-854
65. Arakawa Y, Moriyama M, Taira M, Hayashi N, Tanaka N, Okubo H, Sugitani M. Molecular analysis of hepatitis D virus infection in Miyako Island, a small Japanese island. J Viral Hepat 2000; 7: 375-381
66. Sakugawa H, Nakasone H, Shokita H, Kawakami Y, Nakachi N, Adaniya H, Mizushima T, Nakayoshi T, Kinjo F, Saito A, Taira M, Takaesu H, Onga N. Seroepidemiological study on hepatitis delta virus infection in the Irabu Islands, Okinawa, Japan. J Gastroenterol Hepatol 1997; 12: 299-304
67. Jeong SH, Kim JM, Ahn HJ, Park MJ, Paik KH, Choi W, Kim J, Han CJ, Kim YC, Lee JO, Hong YJ, Park HY, Jeong HH, Yoon MY, Lee M, Lee KH. [The prevalence and clinical characteristics of hepatitis-delta infection in Korea.] Korean J Hepatol 2005; 11: 43-50
68. Vranckx R, Reniers J, Alisjahbana A, Ngantung W, Sugita E, Meheus A. Prevalence of anti-delta antibodies in pregnant women in Bandung, Indonesia. Trop Geogr Med 1988; 40: 17-19
69. Lusida MI, Surayah, Sakugawa H, Nagano-Fujii M, Soetjipto, Mulyanto, Handajani R, Boediwarsono, Setiawan PB, Nidom CA, Ohgimoto S, Hotta H. Genotype and subtype analyses of hepatitis B virus (HBV) and possible co-infection of HBV and hepatitis C virus (HCV) or hepatitis D virus (HDV) in blood donors, patients with chronic liver disease and patients on hemodialysis in Surabaya, Indonesia. Microbiol Immunol 2003; 47: 969-975
70. Sinniah M, Dimitrakakis M, Tan DS. Delta hepatitis in Malaysia. Southeast Asian J Trop Med Public Health 1986; 17: 229-233
71. Tan DS, Dimitrakakis M, Mangalam S, Lopez CG, Ooi BG. Prevalence of hepatitis delta virus infection in Malaysia. Singapore Med J 1989; 30: 34-37
72. Saat Z, Sinniah M, Kin TL, Baharuddin R, Krishnasamy M. A four year review of acute viral hepatitis cases in the east coast of peninsular Malaysia (1994-1997). Southeast Asian J Trop Med Public Health 1999; 30: 106-109
73. Duraisamy G, Zuridah H, Ariffin Y, Kek CS. Hepatitis delta virus in intravenous drug users in Kuala Lumpur. Med J Malaysia 1994; 49: 212-216
74. Louisirirotchanakul S, Wasi C, Uneklabh C, Phutiprawan T, Suwanagool S, Chainuvati T, Thongcharoen P. High prevalence of delta virus infection in Thai intravenous drug abusers. Southeast Asian J Trop Med Public Health 1988; 19: 191-195
75. Theamboonlers A, Hansurabhanon T, Verachai V, Chongsrisawat V, Poovorawan Y. Hepatitis D virus infection in Thailand: HDV genotyping by RT-PCR, RFLP and direct sequencing. Infection 2002; 30: 140-144
76. Louisirirotchanakul S, Myint KS, Srimee B, Kanoksinsombat C, Khamboonruang C, Kunstadter P, Wasi C. The prevalence of viral hepatitis among the Hmong people of northern Thailand. Southeast Asian J Trop Med Public Health 2002; 33: 837-844
77. Sy NE, Macalagay PS, Paulino GP, Fallarme VD, Reyes RS, Sangalang RP, Ranoa CP, Long GW. Serologic classification of acute viral hepatitis at San Lazaro Hospital, Manila, Philippines. Southeast Asian J Trop Med Public Health 1990; 21: 69-75
78. Nguyen VT, McLaws ML, Dore GJ. Highly endemic hepatitis B infection in rural Vietnam. J Gastroenterol Hepatol 2007; 22: 2093-2100
79. Tran HT, Ushijima H, Quang VX, Phuong N, Li TC, Hayashi S, Xuan Lien T, Sata T, Abe K. Prevalence of hepatitis virus types B through E and genotypic distribution of HBV and HCV in Ho Chi Minh City, Vietnam. Hepatol Res 2003; 26: 275-280
80. Dimitrakakis M, Waters MJ, Wootton AL, Gust ID. Epidemiology of hepatitis D virus (delta) infection in Melbourne over a 15-year period. Med J Aust 1986; 145: 128-130
81. Bodsworth NJ, Donovan B, Gold J, Cossart YE. Hepatitis delta virus in homosexual men in Sydney. Genitourin Med 1989; 65: 235-238
82. Brindle RJ, Eglin RP, Parsons AJ, Hill AV, Selkon JB. HTLV-1, HIV-1, hepatitis B and hepatitis delta in the Pacific and South-East Asia: a serological survey. Epidemiol Infect 1988; 100: 153-156
83. Tibbs CJ. Delta hepatitis in Kiribati: a pacific focus. J Med Virol 1989; 29: 130-132
84. Dimitrakakis M, Crowe S, Gust I. Prevalence of delta infection in the western Pacific region. J Med Virol 1986; 18: 335-339
85. Speed BR, Dimitrakakis M, Thoma K, Gust ID. Control of HBV and HDV infection in an isolated Pacific Island: 1. Pattern of infection. J Med Virol 1989; 29: 13-19
86. Ashraf SJ, Arya SC, Arendrup M, Krogsgaard K, Parande CM, Orskov B, Ageel AR. Frequencies of hepatitis B, delta and HTLV-III virus markers in Saudi Arabia. Liver 1986; 6: 73-77
87. el-Hazmi MA, Ramia S. Epidemiology of delta agent infection in Arabia: geographical distribution and prevalence of anti-delta. Vox Sang 1986; 50: 216-219
88. Ramia S, el-Hazmi MA, Vivian PA, Waller DK, Mushahwar IK, Frösner GG. Delta agent infection in Riyadh, Saudi Arabia. Trans R Soc Trop Med Hyg 1987; 81: 317-318
89. Arya SC, Ashraf SJ, Parande CM, Tobeiqi MS, Ageel AR. Hepatitis B and delta markers in primary hepatocellular carcinoma patients in the Gizan area of Saudi Arabia. APMIS Suppl 1988; 3: 30-34
90. Ramia S, Bahakim H. Perinatal transmission of hepatitis B virus-associated hepatitis D virus. Ann Inst Pasteur Virol 1988; 139: 285-290
91. Massoud M, Helmy O, Saleh WA. Hepatitis D anti-bodies in some HBs Ag positive in Saudis at Riyadh. J Egypt Soc Parasitol 1991; 21: 561-565
92. Njoh J, Zimmo S. Prevalence of antibody to hepatitis D virus among HBsAg-positive drug-dependent patients in Jeddah, Saudi Arabia. East Afr Med J 1998; 75: 327-328
93. Al-Traif I, Ali A, Dafalla M, Al-Tamimi W, Qassem L. Prevalence of hepatitis delta antibody among HBsAG carriers in Saudi Arabia. Ann Saudi Med 2004; 24: 343-344
94. Aghanashinikar PN, al-Dhahry SH, al-Marhuby HA, Buhl MR, Daar AS, Al-Hasani MK. Prevalence of hepatitis B, hepatitis delta, and human immunodeficiency virus infections in Omani patients with renal diseases. Transplant Proc 1992; 24: 1913-1914
95. Al-Dhahry SS, Aghanashinikar PN, Al-Marhuby HA, Buhl MR, Daar AS, Al-Hasani MK. Hepatitis B, delta and human immunodeficiency virus infections among Omani patients with renal diseases: A seroprevalence study. Ann Saudi Med 1994; 14: 312-315
96. Farci P, Burroughs AK, Thomas HC, Shamma'a M. Delta hepatitis in Lebanon. Prevalence studies and a report on six siblings with chronic delta-positive active hepatitis. J Hepatol 1987; 4: 224-228
97. Ramia S, El-Zaatari M, Sharara AI, Ramlawi F, Farhat B. Current prevalence of hepatitis delta virus (HDV) infection and the range of HDV genotypes in Lebanon. Epidemiol Infect 2007; 135: 959-962
98. Yurdaydin C. Delta hepatitis in Turkey: decreasing but not vanishing and still of concern. Turk J Gastroenterol 2006; 17: 74-75
99. Deǧertekin H, Yalçin K, Yakut M, Yurdaydin C. Seropositivity for delta hepatitis in patients with chronic hepatitis B and liver cirrhosis in Turkey: a meta-analysis. Liver Int 2008; 28: 494-498
100. el Zayadi A, Ponzetto A, Selim O, Forzani B, Lavarini C, Rizzetto M. Prevalence of delta antibodies among urban HBsAg-positive chronic liver disease patients in Egypt. Hepatogastroenterology 1988; 35: 313-315
101. Darwish MA, Shaker M, Raslan OS, Abdel-Raouf T. Delta virus infection in Egypt. J Egypt Public Health Assoc 1992; 67: 147-161
102. Morcos MM, Mikhail TH, Hanna WM, Abdel-Fattah S, el-Rasad MM, Wassef EL. The prevalence of delta virus infection in chronic liver disease in Egyptian children in comparison with some other countries. Panminerva Med 2000; 42: 97-100